HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SYNE4
spectrin repeat containing nuclear envelope family member 4
Chromosome 19 Β· 19q13.12
NCBI Gene: 163183Ensembl: ENSG00000181392.18HGNC: HGNC:26703UniProt: Q8N205
22PubMed Papers
21Diseases
0Drugs
43Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingestablishment of epithelial cell apical/basal polaritynuclear outer membranenuclear envelopehearing loss, autosomal recessivedeafnessnonsyndromic genetic hearing lossautosomal dominant nonsyndromic hearing loss
✦AI Summary

SYNE4 encodes nesprin-4, a nuclear envelope protein that functions as a component of the LINC (Linker of Nucleoskeleton and Cytoskeleton) complex, connecting the nuclear lamina to the cytoskeleton 1. The protein localizes to the outer nuclear membrane and is essential for proper nuclear positioning in cells 1. Mechanistically, nesprin-4 acts as a kinesin-1 cargo through a conserved 4-amino acid motif, enabling microtubule-dependent nuclear positioning 2. This interaction is particularly critical in cochlear outer hair cells (OHCs), where nesprin-4 mediates basal nuclear localization necessary for cell viability and function 2. SYNE4 mutations cause autosomal recessive deafness (DFNB76), characterized by progressive high-frequency sensorineural hearing loss 13. In affected individuals and mouse models, SYNE4 deficiency leads to nuclear mislocalization in OHCs, followed by cell degeneration and hearing loss that coincides with the onset of electromotility 12. The therapeutic potential has been demonstrated through successful AAV gene therapy in neonatal Syne4-/- mice, which restored auditory function and hair cell morphology 4. Additionally, SYNE4 expression is regulated by transcriptional machinery involving GAS41, BRD2, and the Mediator complex, highlighting its role in nuclear shape maintenance 5.

Sources cited
1
SYNE4 encodes nesprin-4, a LINC complex component essential for nuclear positioning and hearing, with mutations causing progressive hearing loss
PMID: 23348741
2
Nesprin-4 interacts with kinesin-1 through a conserved motif for nuclear positioning in outer hair cells
PMID: 36211453
3
Novel SYNE4 variant causes non-syndromic high-frequency sensorineural hearing loss
PMID: 28958982
4
AAV gene therapy successfully rescues hearing in Syne4-/- mouse model
PMID: 33350593
5
SYNE4 expression is regulated by GAS41, BRD2, and Mediator complex for nuclear shape maintenance
PMID: 38964523
Disease Associationsβ“˜21
hearing loss, autosomal recessiveOpen Targets
0.65Moderate
deafnessOpen Targets
0.62Moderate
nonsyndromic genetic hearing lossOpen Targets
0.54Moderate
autosomal dominant nonsyndromic hearing lossOpen Targets
0.51Moderate
Rare genetic deafnessOpen Targets
0.27Weak
Non-syndromic genetic deafnessOpen Targets
0.18Weak
autosomal recessive nonsyndromic hearing loss 9Open Targets
0.05Suggestive
pancreatic adenocarcinomaOpen Targets
0.04Suggestive
ovarian carcinomaOpen Targets
0.02Suggestive
clear cell renal carcinomaOpen Targets
0.01Suggestive
hearing lossOpen Targets
0.01Suggestive
neoplasmOpen Targets
0.01Suggestive
cancerOpen Targets
0.00Suggestive
colorectal carcinomaOpen Targets
0.00Suggestive
infertilityOpen Targets
0.00Suggestive
psoriasisOpen Targets
0.00Suggestive
asthmaOpen Targets
0.00Suggestive
invasive breast ductal carcinomaOpen Targets
0.00Suggestive
FibroadenomaOpen Targets
0.00Suggestive
breast ductal carcinoma in situOpen Targets
0.00Suggestive
Deafness, autosomal recessive, 76UniProt
Pathogenic Variants43
NM_001039876.3(SYNE4):c.121_122dup (p.Ser41fs)Pathogenic
not provided|Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜…β˜†β˜†2026β†’ Residue 41
NM_001039876.3(SYNE4):c.559C>T (p.Arg187Ter)Pathogenic
Rare genetic deafness|not provided|Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜…β˜†β˜†2025β†’ Residue 187
NM_001039876.3(SYNE4):c.973-2A>TLikely pathogenic
not provided|Nonsyndromic genetic hearing loss
β˜…β˜…β˜†β˜†2025
NM_001039876.3(SYNE4):c.889C>T (p.Arg297Ter)Pathogenic
Nonsyndromic genetic hearing loss|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 297
NM_001039876.3(SYNE4):c.972+1G>APathogenic
not provided|Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜…β˜†β˜†2024
NM_001039876.3(SYNE4):c.442C>T (p.Arg148Ter)Pathogenic
not provided|Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜…β˜†β˜†2024β†’ Residue 148
NM_001039876.3(SYNE4):c.653T>A (p.Leu218Ter)Likely pathogenic
Nonsyndromic genetic hearing loss|Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜…β˜†β˜†2024β†’ Residue 218
NM_001039876.3(SYNE4):c.377del (p.Gly126fs)Likely pathogenic
Nonsyndromic genetic hearing loss|Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜…β˜†β˜†2024β†’ Residue 126
NM_001039876.3(SYNE4):c.662_666del (p.Glu221fs)Pathogenic
not provided|Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜…β˜†β˜†2024β†’ Residue 221
NM_001039876.3(SYNE4):c.618+2T>ALikely pathogenic
not provided|Autosomal recessive nonsyndromic hearing loss 76|Ovarian serous cystadenocarcinoma
β˜…β˜…β˜†β˜†2024
NM_001039876.3(SYNE4):c.96dup (p.Val33fs)Pathogenic
not provided|Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜…β˜†β˜†2024β†’ Residue 33
NM_001039876.3(SYNE4):c.253_259dup (p.Ala87fs)Pathogenic
not provided|Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜…β˜†β˜†2024β†’ Residue 87
NM_001039876.3(SYNE4):c.702del (p.Trp236fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 236
NM_001039876.3(SYNE4):c.129-1G>TPathogenic
not provided
β˜…β˜…β˜†β˜†2024
NM_001039876.3(SYNE4):c.336C>A (p.Cys112Ter)Pathogenic
Autosomal recessive nonsyndromic hearing loss 76|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 112
NM_001039876.3(SYNE4):c.415del (p.Gln139fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 139
NM_001039876.3(SYNE4):c.742del (p.Glu248fs)Pathogenic
Nonsyndromic genetic hearing loss
β˜…β˜†β˜†β˜†2025β†’ Residue 248
NM_001039876.3(SYNE4):c.228_229del (p.Trp77fs)Pathogenic
Autosomal recessive nonsyndromic hearing loss 76|not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 77
NM_001039876.3(SYNE4):c.128+1G>ALikely pathogenic
Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜†β˜†β˜†2024
NM_001039876.3(SYNE4):c.742dup (p.Glu248fs)Likely pathogenic
Autosomal recessive nonsyndromic hearing loss 76
β˜…β˜†β˜†β˜†2024β†’ Residue 248
View on ClinVar β†—
Related Genes
SUN1Protein interaction99%SUN2Protein interaction99%KIF5BProtein interaction93%KLC1Protein interaction93%KLC2Protein interaction93%KLC3Protein interaction93%
Tissue Expression6 tissues
Liver
100%
Lung
18%
Ovary
8%
Bone Marrow
6%
Brain
2%
Heart
1%
Gene Interaction Network
Click a node to explore
SYNE4SUN1SUN2KIF5BKLC1KLC2KLC3
PROTEIN STRUCTURE
Preparing viewer…
PDB6WMD Β· 1.50 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.25LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.96 [0.75–1.25]
RankingsWhere SYNE4 stands among ~20K protein-coding genes
  • #13,758of 20,598
    Most Researched22
  • #1,479of 5,498
    Most Pathogenic Variants43
  • #13,201of 17,882
    Most Constrained (LOEUF)1.25
Genes detectedSYNE4
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
A Nesprin-4/kinesin-1 cargo model for nuclear positioning in cochlear outer hair cells.
PMID: 36211453
Front Cell Dev Biol Β· 2022
1.00
2
Nucleocytoplasmic connections and deafness.
PMID: 23348730
J Clin Invest Β· 2013
0.90
3
Homozygous variants in EIF3K associated with neurodevelopmental delay, microcephaly, and growth retardation.
PMID: 40219605
HGG Adv Β· 2025
0.80
4
A Novel Variant in
PMID: 28958982
Balkan Med J Β· 2018
0.70
5
Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness.
PMID: 33350593
EMBO Mol Med Β· 2021
0.60